Margriet A. Hulsker
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Uniform sarcolemmal dystrophin expression is required to prevent extracellular microRNA release and improve dystrophic pathology.
Journal: Journal of cachexia, sarcopenia and muscle
Published: August 21, 2019
Voluntary exercise improves muscle function and does not exacerbate muscle and heart pathology in aged Duchenne muscular dystrophy mice.
Journal: Journal of molecular and cellular cardiology
Published: August 20, 2018
A dystrophic Duchenne mouse model for testing human antisense oligonucleotides.
Journal: PloS one
Published: July 20, 2017
Accurate Dystrophin Quantification in Mouse Tissue; Identification of New and Evaluation of Existing Methods.
Journal: Journal of neuromuscular diseases
Published: November 18, 2016
Preclinical studies on intestinal administration of antisense oligonucleotides as a model for oral delivery for treatment of duchenne muscular dystrophy.
Journal: Molecular therapy. Nucleic acids
Published: August 20, 2014
Studying the role of dystrophin-associated proteins in influencing Becker muscular dystrophy disease severity.
Journal: Neuromuscular disorders : NMD
Published: April 25, 2014
Dystrophin levels and clinical severity in Becker muscular dystrophy patients.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: December 03, 2013
Low dystrophin levels in heart can delay heart failure in mdx mice.
Journal: Journal of molecular and cellular cardiology
Published: August 30, 2013
Clinical characterisation of Becker muscular dystrophy patients predicts favourable outcome in exon-skipping therapy.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: May 14, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026